| A New Panel Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population | 33301877 | PMC8102017 | Journal | 2021 | 10.1053/j.ajkd.2020.11.005 | AASK Trial | 20522 | Secondary Research |
| APOL1 Genotype, Proteinuria, and the Risk of Kidney Failure: A Secondary Analysis of the AASK (African American Study of Kidney Disease and Hypertension) and CRIC (Chronic Renal Insufficiency Cohort) Studies. | 36479469 | PMC9720339 | Journal | 2022 | 10.1016/j.xkme.2022.100563 | AASK Cohort | 22550 | Secondary Research |
| APOL1 Genotype, Proteinuria, and the Risk of Kidney Failure: A Secondary Analysis of the AASK and CRIC Studies | 36479469 | | Journal | 2022 | 10.1016/j.xkme.2022.100563 | AASK Trial, CRIC, AASK Cohort | 22088, 22550 | Secondary Research |
| APOL1 Renal-Risk Variants Do Not Associate With Incident Cardiovascular Disease or Mortality in the Systolic Blood Pressure Intervention Trial | 28758155 | PMC5527675 | Journal | 2017 | 10.1016/j.ekir.2017.03.008 | AASK Trial | 20241, 20271, 20272 | Secondary Research |
| APOL1 Risk Variants and Subclinical Cardiovascular Disease in Incident Hemodialysis Patients | 33615058 | PMC7879092 | Journal | 2020 | 10.1016/j.ekir.2020.11.006 | AASK Trial | 21579 | Secondary Research |
| APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes | 25054777 | PMC4281283 | Journal | 2014 | 10.1038/ki.2014.255 | AASK Trial | 20241, 20271, 20272 | Secondary Research |
| Acute Declines in Estimated GFR in Blood Pressure Target Trials and Risk of Adverse Outcomes | 37269972 | | Journal | 2023 | 10.1053/j.ajkd.2023.03.013 | MDRD, AASK Trial, AASK Cohort | 4528 | Secondary Research |
| Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium | 30630856 | PMC6481269 | Journal | 2019 | 10.1136/bmj.k5301 | AASK Trial | 20733 | Secondary Research |
| Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering
pharmacotherapy for the prevention of cardiovascular disease and death: an individual
participant-level data meta-analysis | 34461040 | PMC8473559 | Journal | 2021 | 10.1016/S0140-6736(21)01921-8 | AASK Trial | 22859 | Secondary Research |
| Antihypertensive drug effects on long-term blood pressure: an individual-level data metaanalysis of randomised clinical trials | 35058294 | PMC9340038 | Journal | 2022 | 10.1136/heartjnl-2021-320171 | AASK Trial | 22859 | Secondary Research |
| Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials | 35058294 | PMC9340038 | Journal | 2022 | 10.1136/heartjnl-2021-320171 | AASK Trial | 22859 | Secondary Research |
| Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis | 33794209 | PMC8024901 | Journal | 2021 | 10.1016/S1470-2045(21)00033-4 | AASK Trial | 22859 | Secondary Research |
| Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis | 33794209 | PMC8024901 | Journal | 2021 | 10.1016/S1470-2045(21)00033-4 | AASK Trial | 22859 | Secondary Research |
| Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial | 25029429 | PMC4281289 | Journal | 2014 | 10.1038/ki.2014.254 | AASK Trial | 20241, 20271, 20272 | Secondary Research |
| Associations of Baseline and Longitudinal Uromodulin with ESKD and Mortality: Results from AASK | 37690632 | | Journal | 2023 | 10.1053/j.ajkd.2023.05.017 | AASK Trial | 21579 | Secondary Research |
| Baseline Diastolic Blood Pressure and Cardiovascular Outcomes in SPRINT Participants with Chronic Kidney Disease | 35369376 | PMC8809286 | Journal | 2020 | 10.34067/KID.0000982019 | AASK Cohort | 20629 | Secondary Research |
| Blood pressure targets for the treatment of people with hypertension and cardiovascular disease | 36398903 | | Journal | 2022 | 10.1002/14651858.CD010315 | AASK Trial, MDRD | 22650 | Secondary Research |
| Canagliflozin, serum magnesium and cardiovascular outcomes—Analysis from the CANVAS Program | 34277971 | PMC8279612 | Journal | 2021 | 10.1002/edm2.247 | AASK Cohort | 20629 | Secondary Research |
| Circulating Branched-Chain Amino Acids, Incident Cardiovascular Disease, and Mortality in the African American Study of Kidney Disease and Hypertension. | 36716198 | PMC9974782 | Journal | 2023 | 10.1161/CIRCGEN.122.003729 | AASK Trial | 20733 | Secondary Research |
| Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial | 28985268 | PMC5861531 | Journal | 2017 | 10.1093/ajh/hpx138 | AASK Trial | 20271 | Secondary Research |
| Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury | 37292692 | | Journal | 2023 | 10.1101/2023.05.16.23290051 | AASK Trial, ASSESS-AKI | 23204 | Secondary Research |
| Comparison of Aptamer-based and Antibody-based Assays for Protein Quantification in Chronic Kidney Disease | 35197258 | PMC8975030 | Journal | 2022 | 10.2215/CJN.11700921 | AASK Trial | 21579 | Secondary Research |
| Diagnosis, Education, and Care of Patients with APOL1-Associated Nephropathy: A Delphi Consensus and Systematic Review | 33853887 | PMC8425659 | Journal | 2021 | 10.1681/ASN.2020101399 | AASK Trial | 20271 | Secondary Research |
| Dietary acid load: A novel nutritional target in chronic kidney disease? | 23439373 | PMC3604792 | Journal | 2013 | 10.1053/j.ackd.2012.11.001 | AASK Trial | 20048 | Secondary Research |
| Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation | 32362229 | PMC7225060 | Journal | 2020 | 10.1161/HYPERTENSIONAHA.120.14766 | AASK Cohort | 20629 | Secondary Research |
| Enhancing individual glomerular filtration rate assessment: can we trust the equation? | https://pubmed.ncbi.nlm.nih.gov/39885391/ | | Journal | 2025 | 10.1186/s12882-025-03972-0 | MDRD, PERL, DCCT/EDIC, AASK Trial, ALTOLD, AASK Cohort, CRIC, CRISP | 23649 | Secondary Research |
| Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial) | 33333147 | PMC8200370 | Journal | 2021 | 10.1053/j.ajkd.2020.10.016 | AASK Cohort | 20955 | Secondary Research |
| Estimating glomerular filtration in young people | 39314869 | | Journal | 2024 | https:/doi.org/10.1093/ckj/sfae261 | MDRD, PERL, AASK Trial, DCCT/EDIC, AASK Cohort, CRISP, CRIC, ALTOLD | 23649 | Secondary Research |
| Estimating glomerular filtration in young people | 39314869 | | Journal | 2024 | 10.1093/ckj/sfae261 | AASK Trial, CRIC, AASK Cohort | 23401 | Secondary Research |
| Factors Associated with Failure to Achieve the Intensive Systolic Blood Pressure Target in SPRINT | 33131314 | PMC7831968 | Journal | 2020 | 10.1161/HYPERTENSIONAHA.120.16155 | AASK Cohort | 20629 | Secondary Research |
| Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis | 28062677 | PMC5220652 | Journal | 2017 | 10.2215/CJN.03660316 | AASK Cohort | 20787 | Secondary Research |
| GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD. | 26362696 | PMC4695294 | Journal | 2016 | 10.1053/j.ajkd.2015.07.025 | AASK Trial | 20522 | Secondary Research |
| Gene Set Enrichment Analyses Identify Pathways Involved in Genetic
Risk for Diabetic Retinopathy | 34166655 | PMC8678352 | Journal | 2021 | 10.1016/j.ajo.2021.06.014 | AASK Trial | 20271 | Secondary Research |
| Genome-wide association study of serum metabolites in the African American Study of Kidney Disease and Hypertension. | 33838163 | PMC8583323 | Journal | 2021 | 10.1016/j.kint.2021.03.026 | AASK Trial | 20733 | Secondary Research |
| Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared to Standard Blood Pressure Control | 29021322 | PMC5760457 | Journal | 2017 | 10.1161/CIRCULATIONAHA.117.030848 | AASK Trial | 20271 | Secondary Research |
| Integrated proteomic and metabolomic modules identified as biomarkers of mortality in the Atherosclerosis Risk in Communities study and the African American Study of Kidney Disease and Hypertension. | 36329547 | PMC9635174 | Journal | 2022 | 10.1186/s40246-022-00425-9 | AASK Trial | 20733 | Secondary Research |
| Integrating APOL1 Kidney-risk Variant Testing in Live Kidney Donor Evaluation: An Expert Panel Opinion | 33534524 | PMC8994118 | Journal | 2022 | 10.1097/TP.0000000000003641 | AASK Trial | 20271 | Secondary Research |
| Intensive blood pressure control in patients with chronic kidney disease and risk for adverse outcomes | | | Journal | 2023 | | AASK Trial, MDRD, AASK Cohort | 4528 | Secondary Research |
| Longitudinal TNFR1 and TNFR2 and Kidney Outcomes: Results from AASK and VA NEPHRON-D | 35314457 | PMC9063900 | Journal | 2022 | 10.1681/ASN.2021060735 | AASK Trial | 21579 | Secondary Research |
| Medical records-based chronic kidney disease phenotype for clinical care and “big data” observational and genetic studies | 33850243 | PMC8044136 | Journal | 2021 | 10.1038/s41746-021-00428-1 | AASK Cohort | 22384 | Secondary Research |
| Metabolite Biomarkers of CKD Progression in Children | 34362785 | PMC8455058 | Journal | 2021 | 10.2215/CJN.00220121 | AASK Trial | 20733 | Secondary Research |
| Multiethnic Genome-wide Association Study of Subclinical
Atherosclerosis in Individuals with Type 2 Diabetes | 34241534 | PMC8435075 | Journal | 2021 | 10.1161/CIRCGEN.120.003258 | AASK Trial | 20271 | Secondary Research |
| Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results from SPRINT | 31983312 | PMC7261502 | Journal | 2020 | 10.1161/HYPERTENSIONAHA.119.14309 | AASK Cohort | 22006 | Secondary Research |
| Performance of the European Kidney Function Consortium (EKFC) creatinine-based equation in American cohorts | 38101514 | | Journal | 2023 | 10.1016/j.kint.2023.11.024 | AASK Trial, MDRD, DCCT/EDIC, PERL, ALTOLD, CRISP, CRIC, AASK Cohort | 23649 | Secondary Research |
| Performance of the European Kidney Function Consortium (EKFC) creatinine-based equation in United States cohorts. | 38101514 | | Journal | 2024 | 10.1016/j.kint.2023.11.024 | AASK Trial, AASK Cohort, CRIC | 23401 | Secondary Research |
| Proteomics: Progress and Promise of High-Throughput Proteomics in Chronic Kidney Disease | 37076045 | PMC10326701 | Journal | 2023 | 10.1016/j.mcpro.2023.100550 | AASK Trial | 20733 | Secondary Research |
| Race, APOL1 Risk Variants, and Clinical Outcomes among Older Adults: The ARIC Study | 32894582 | PMC7855571 | Journal | 2021 | 10.1111/jgs.16797 | AASK Trial | 20733, 21008, 21579 | Secondary Research |
| Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report From the NKF-ASN Task Force | 33845065 | PMC8238889 | Journal | 2021 | 10.1053/j.ajkd.2021.03.008 | AASK Trial | 20522 | Secondary Research |
| Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report from the NKF-ASN Task Force | 33837122 | PMC8259639 | Journal | 2021 | 10.1681/ASN.2021010039 | AASK Trial | 20522 | Secondary Research |
| Reducing Kidney Function Decline in Patients With CKD: Core Curriculum 2021 | 33892998 | PMC8227808 | Journal | 2021 | 10.1053/j.ajkd.2020.12.022 | AASK Trial | 20733, 21008, 21579 | Secondary Research |
